NCT02564848View on ClinicalTrials.gov

Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 22, 2016

Primary Completion Date

March 31, 2029

Study Completion Date

March 31, 2029

Conditions
Breast Cancer
Interventions
PROCEDURE

Lumpectomy without sentinel node biopsy

Biopsy of the sentinel node is considered standard of care treatment for women with localized breast cancer. The procedure will be eliminated at time of lumpectomy.

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT02564848 - Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65 | Biotech Hunter | Biotech Hunter